Dose-Ranging Study of the Bimatoprost Ocular Insert

NCT02358369 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Bimatoprost
DRUG: Timolol 0.5%
DEVICE: Placebo Ocular Insert
DRUG: Placebo Eye Drops

Sponsor

ForSight Vision5, Inc.